In pancreatic cancer, SLC28A1 was down-regulated when compared with non-neoplastic tissues [20], and high tumor transcript levels of SLC28A1 predicted a poor OS in pancreatic ductal adenocarcinomas patients. The gene discussed is SLC28A1; the disease is familial pancreatic carcinoma.